An investor asked Jinkai Biosciences if the company has any collaboration with Novo Nordisk in the weight loss drug business and what products are supplied. Jinkai Biosciences replied on the interactive platform that the company provides intermediate services for SNAC, a promoter of Simeglutide oral penetration.
金凯生科：为司美格鲁肽口服渗透促进剂SNAC提供中间体服务
Jinkai Biosciences provides intermediate services for SNAC, a promoter of Simeglutide oral penetration, to Simcere Pharmaceutical Group.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.